Company CVAbout Kerala Ayurveda Ltd 
Kerala Ayurveda Ltd
Micro Cap
Pharmaceuticals & Drugs
Kerala Ayurveda Ltd was established on 6th July 1992. The Company is engaged in manufacture of Ayurveda products, Ayurveda Research, Academies, Clinics, Hospitals, Ayurvedic Wellness Resorts and Services , cultivation of herbs and maintaining herbarium of medicinal plants. The Company emerged as a frontline manufacturer of speciality patent ayurvedic medicines - tussnil, liposem and mathrukalpam. The company came out with a public issue in Feb.
Company Coordinates
Company Details
VII/415 Nedumbassery, Athani P O Aluva Ernakulam Kerala : 683585
Registrar Details
Integrated Enterprises (India) Ltd , II Floor , Kences Towers, No 1 Ramakrishna Street, North Usman Road, T Nagar, Chennai
Capital StructureCapital Structure
Present Equity Capital
INR 12.03 Cr
Number of Shares
1.2 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
04-Jan-2024
1.2
12.03
921781
10
Preferential basis
11-Oct-2023
1.11
11.11
550670
10
Preferential basis
31-Mar-2007
1.06
10.56
2497500
10
Conversion of Warrants
31-Mar-2007
1.06
10.56
2497500
10
Conversion of Warrants
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
13.3599
Mutual Funds
Held by 1 Schemes (0.02%)
FIIs
Held by 0 FIIs
Promoter with highest holding
Katra Holdings Ltd (53.97%)
Highest Public shareholder
Porinju Veliyath (5.18%)
Individual Investors Holdings
32.19%
Board of Directors
Management
Designation
Remuneration
Ramesh Vangal
Chairman (Non-Executive)
0
K Anilkumar
Whole-time Director
0
Anand Subramanian
Director
0
Harish Menon
Independent Director
0
Gokul Patnaik
Director
0
S Krishnamurthy
Independent Director
0
Ashitha B R
Company Sec. & Compli. Officer
0
Shilpa Kiran Gududur
Independent Director
0
Rajesh Sharma
Independent Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Sale of Services - Other Operational Income
0.11
0.00%
Sale of Services - Other Operational Income
Stock DNARevenue and Profits:
Net Sales:
31 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-3 Cr
Pharmaceuticals & Drugs
INR 409 Cr (Micro Cap)
409.00
33
0.00%
1.56
7.32%
11.35
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
